Status:
COMPLETED
Keto Drinks as a Meal Primer in Patients With Type 2 Diabetes
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Type 2 Diabetes
Ketoses, Metabolic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of this clinical trial is to study the effects of orally administered ketone drinks containing the ketone body, 3-hydroxybutyrate (3-OHB), just before a meal in patients with type 2...
Eligibility Criteria
Inclusion
- Type 2 diabetes diagnosis, metformin treated or dietary treated
- HbA1C \< 80 mmol/mol
- 25 \< BMI \< 35
- Written consent
Exclusion
- Severe comorbidity
- Treatment with insulin, GLP-1 analogues, SGLT-2-inhibitors or sulfonylureas
- Specific diets, e.g. ketogenic diet
- PI finds the patient not fit (e.g. mental illness, too nervous, unacceptable screening blood tests or other)
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05263401
Start Date
January 1 2022
End Date
September 30 2022
Last Update
April 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical research laboratory, Department of endocrinology, Aarhus University Hospital
Aarhus, Denmark, 8000